Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spinal Cord Injury Rehabilitation: Gut Dysbiosis and Immune Biomarkers As Functional Prognosis Tools and New Therapeutic Targets - a Longitudinal Prospective Cohort Study

NCT06892106 is registered in ClinicalTrials.gov with Centro Academico Clínico Egas Moniz Health Alliance as lead sponsor.

NCT NCT06892106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06892106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spinal Cord Injury Rehabilitation: Gut Dysbiosis and Immune Biomarkers As Functional Prognosis Tools and New Therapeutic Targets - a Longitudinal Prospective Cohort Study
Lead sponsor
Centro Academico Clínico Egas Moniz Health Alliance
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
October 16, 2023
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut dysbiosis, immune dysfunction, spinal cord injury